Consultations
See the list below:
Nutritionist or dietitian
Nephrologist
Medication Summary
Therapy for patients with APSGN is symptomatic in nature and
depends on the clinical severity of the illness. The major aims are to
control the edema and blood pressure.
During the acute phase of the disease, salt and water should
be restricted. If significant edema or hypertension develops,
diuretics should be administered. Loop diuretics increase urinary
output and consequently improve cardiovascular congestion and
hypertension.
For hypertension not controlled by diuretics, calcium channel
blockers or angiotensin-converting enzyme inhibitors are generally
useful. For malignant hypertension, intravenous nitroprusside or
other parenteral agents are used.
The indications for dialysis include life-threatening hyperkalemia
and clinical manifestations of uremia. Steroids, immunosuppressive
agents, and plasmapheresis are not generally indicated. In patients
with rapidly progressive renal failure, a renal biopsy is indicated. If
the biopsy findings show evidence of crescentic glomerulonephritis
with more than 30% of the glomeruli involved, a short course of
intravenous pulse steroid therapy is recommended (500 mg to 1
g/1.73 m2 of methylprednisone qd for 3-5 d). However, no controlled
clinical trials have evaluated such therapy. Long-term treatment
with steroids or immunosuppressives is not recommended.
1. DIURETICS
2. CALCIUM CHANNEL BLOCKERS
3. ANGIOTENSIN-CONVERTING ENZYME INHIBITORS
4. VASODILATORS
5. ANTIBIOTIC